.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Moodys
Medtronic
Johnson and Johnson
Accenture
QuintilesIMS
Cerilliant
Cantor Fitzgerald
Express Scripts
Federal Trade Commission

Generated: December 16, 2017

DrugPatentWatch Database Preview

Sulfur hexafluoride lipid-type a microspheres - Generic Drug Details

« Back to Dashboard

What are the generic sources for sulfur hexafluoride lipid-type a microspheres and what is the scope of sulfur hexafluoride lipid-type a microspheres freedom to operate?

Sulfur hexafluoride lipid-type a microspheres
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sulfur hexafluoride lipid-type a microspheres has one hundred and forty-one patent family members in twenty-eight countries and seven supplementary protection certificates in five countries.

There are two drug master file entries for sulfur hexafluoride lipid-type a microspheres. One supplier is listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
BraccoLUMASONsulfur hexafluoride lipid-type a microspheresFOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► Subscribe► Subscribe
BraccoLUMASONsulfur hexafluoride lipid-type a microspheresFOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► Subscribe► Subscribe
BraccoLUMASONsulfur hexafluoride lipid-type a microspheresFOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► SubscribeYY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: sulfur hexafluoride lipid-type a microspheres

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,110,443 Dry stable formation to produce microbubble suspension for ultrasound► Subscribe
5,908,610 Stable microbubble suspensions comprising saturated phospholipios for ultrasonic echography► Subscribe
5,567,414 Stable microbubbles suspensions injectable into living organisms► Subscribe
6,136,293 Stable microbubbles suspensions containing saturated lamellar phospholipids► Subscribe
RE39146Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof► Subscribe
5,863,520 Method of echographic imaging using polymeric gas or air filled microballoons► Subscribe
7,083,778Ultrasound contrast agents and methods of making and using them► Subscribe
7,033,574Stable microbubbles suspensions injectable into living organisms► Subscribe
5,711,933 Method of making polymeric gas or air filled microballoons for ultrasonic echography► Subscribe
5,271,928 Stable microbubbles suspensions injectable into living organisms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sulfur hexafluoride lipid-type a microspheres

Country Document Number Estimated Expiration
Japan2003221350► Subscribe
New Zealand276167► Subscribe
Australia3186093► Subscribe
HungaryT58508► Subscribe
Australia3431795► Subscribe
Australia2618197► Subscribe
Australia1033095► Subscribe
China1088456► Subscribe
Australia5336294► Subscribe
Austria234638► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0004France► SubscribePRODUCT NAME: CEFTOLOZANE,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,PLUS PARTICULIEREMENT UN SEL D'ACIDE SULFURIQUE; REGISTRATION NO/DATE: EU/1/15/1032 20150922
0061Netherlands► SubscribePRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001 20010326
C0036France► SubscribePRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001 20010326
00061Netherlands► SubscribePRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
/2001Austria► SubscribePRODUCT NAME: SCHWEFELHEXAFLUORID ENTHALTENDE, DURCH PHOSPHORLIPID STABILISIERTE MIKROBLAESCHEN; REGISTRATION NO/DATE: EU/1/01/177/001, EU/1/01/177/002 20010326
943Luxembourg► SubscribePRODUCT NAME: CEFTOLOZANE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, EN PARTICULIER UN SEL D'ACIDE SULFURIQUE (ZERBAXA); FIRST REGISTRATION: 20150922
C/GB01/043United Kingdom► SubscribePRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTERED: UK EU/1/01/177/001 20010326; UK EU/1/01/177/002 20010326
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Julphar
Chubb
Covington
Moodys
Farmers Insurance
Argus Health
Daiichi Sankyo
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot